Treatment of bone and joint infection with teicoplanin: A retrospective analysis of 50 cases

International Journal of Antimicrobial Agents

Volumn 7, Issue 1, 1996, Pages 49-51

  Dacquet, V ^a  

^a Institut Calot Helio Marin   (France)

Author keywords

Bone infection; Gram positive organisms; Joint infection; Teicoplanin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; FUSIDIC ACID; TEICOPLANIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE KIDNEY FUNCTION RELATION; DRUG EFFICACY; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; INFECTIOUS ARTHRITIS; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029999113     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(96)00009-X     Document Type: Article

References (6)

1. LeFrock JL, Ristuccia AM, Ristuccia PA, Quenzer RW, Haggerty PG, Allen JE, Lettau LA, Schwartz R, Appleby D. Teicoplanin in the treatment of bone and joint infections. Acta Chir 1992;S567:9-13.
2. Grüneberg RN. Treatment of bone, joint and vascular-access-associated Gram-positive bacterial infections with teicoplanin. Antimicrob Agents Chemother 1990;34:2392-2397.
3. Wilson APR, Taylor B, Treasure T, Grüneberg RN, Patton K, Felmingham D, Sturridge MF. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. J Antimicrob Chemother 1988;21:201-212.
4. Wilson APR, Grüneberg RN, Neu H. A critical review of the dosage of teicoplanin in Europe and the USA. Int J Antimicrob Agents 1994;4:S1-S30.
5. Lewis P, Garaud JJ, Parenti F. A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteria. J Antimicrob Chemother 1988;21(Suppl A):61-67.
6. Glupczynski Y, Lagast H, Van der Auwera P, Thys JP, Crokaert F. Clinical evaluation of teicoplanin for therapy of severe infections caused by Gram-positive bacteria. Antimicrob Agents Chemother 1986;29:52-57.